Respiratory syncytial virus (RSV) poses a significant, often overlooked, risk for serious cardiovascular complications in ...

Each year in the UK, 30,000 children under the age of five are hospitalised with RSV and it causes around 30 infant deaths.

Two recent studies published this week assess the low uptake of respiratory syncytial virus (RSV) vaccine among US veterans ...

A new respiratory syncytial virus vaccine to protect infants from severe illness is available in South Africa’s private ...

Winter is here, and with it come higher rates of respiratory illnesses. If you've been struck down recently with a sore ...

The CDC recently updated RSV vaccine recommendations to include certain adults aged 50 and up. When is the best time to get ...

Respiratory syncytial virus is common but it can be dangerous for some infants and young kids. Here's everything parents need to know.

Sanofi has struck a deal to buy Vicebio for $1.15 billion upfront, securing preclin | Sanofi has struck a deal to buy Vicebio ...

Sanofi acquires Vicebio for $1.15 billion, adding a next-gen RSV-hMPV vaccine and ‘Molecular Clamp' tech to strengthen its respiratory vaccine pipeline.

Vaccination of pregnant women has been linked to a drop in newborns being admitted to hospital with a serious lung infection, ...

Sanofi has announced that it will be expanding its respiratory vaccines pipeline by acquiring UK-based Vicebio for up to ...

Some States Reporting a Dramatic Rise in RSV: Here's What You Need to Know About the Respiratory Virus Young children and adults over 65, or those with chronic illnesses, are at a high risk of ...